Researchers have achieved impressive results in animal studies with a new weight-loss drug that has no GLP-1-style side ...

Some people are not taking weight-loss medications responsibly, the physician says, and don't realize their full implications ...

The US Food and Drug Administration (FDA) has issued warning letters to four companies selling unapproved glucagon-like ...

Newer glucose-lowering drugs reduce the risk for late-onset seizures and epilepsy by 24%, with GLP-1 RAs cutting the risk by ...

Researchers explore the therapeutic potential and clinical insights of GP1-RAs in the management of metabolic ...

Nutraceuticals offer potential health benefits, from migraine relief to cognitive support, but safety and regulatory issues ...

Individual usage of glucagon like peptide 1 receptor agonists reduced the risk of hospitalization due to alcohol and substance use disorders.

Polyphenols are a diverse group of compounds that contribute to the flavor and health benefits of foods like green tea, ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is currently a pressing public health issue associated with ...

Construction has already begun on the Ozempic-producer’s new Danish production facility and 40,000m² warehouse.

The most-read obesity articles of 2024 mostly focused on insurance coverage of weight loss medications and costs.